MOH DG Lauds Clinical Trial for Severe COVID-19 CasesMOH DG Lauds Clinical Trial for Severe COVID-19 CasesMOH DG Lauds Clinical Trial for Severe COVID-19 CasesMOH DG Lauds Clinical Trial for Severe COVID-19 Cases
  • Who We Are
    • About Us
    • Sime Darby Plantation Worldwide
    • Our Journey
    • Our Products
    • Our Leaders
    • Our Awards and Recognitions
    • Corporate Governance
  • What We Do
    • Our Strategy
    • Our Businesses
  • Innovation
    • Overview
    • GenomeSelect™
    • Precision Agriculture
    • Automating Plantations
    • Eco-Solutions
    • Food Science
    • Innovation Challenge
  • Sustainability
    • Overview
    • Climate Action
    • Human Rights
    • Responsible Sourcing
    • Reports, Policies and Statements
  • Our People
    • Growing Together
    • Opportunities
    • What Do Our People Say?
    • Connect With Us
  • Investor Relations
    • Overview
    • Stock and Shareholder Information
    • Financial Information
    • Operational Information
    • Investor Resources
    • Analyst Coverage
    • ESG Index and Credit Ratings
    • Bursa Announcements
    • Annual Reports and Presentations
Procurement
#SDPnetzero

MOH DG Lauds Clinical Trial for Severe COVID-19 Cases

  • Home
  • Press Releases and Public Updates
  • MOH DG Lauds Clinical Trial for Severe COVID-19 Cases
30 April 2020

MOH DG Lauds Clinical Trial for Severe COVID-19 Cases

Yayasan Sime Darby channels RM600,000 for study on the use of Tocilizumab in preventing severe infections from progressing to critical stage which require ventilation assistance

Kuala Lumpur, 30 April 2020 – Yayasan Sime Darby (YSD) has committed to fund clinical trials led by University Malaysia Medical Centre (UMMC) to treat severe COVID-19 cases utilising Tocilizumab (TCZ), a medication used to treat rheumatoid arthritis, in the fight against the COVID-19 pandemic.

An allocation of RM600,000 will cover the costs of analyser equipment, monitoring kits and control reagents required for clinicians to conduct the potentially life-saving initiative for a period of seven months until October 2020, for 310 selected patients.

In collaboration with the Ministry of Health (MoH), the innovative clinical trials are conducted at four hospitals (UMMC, Hospital Sungai Buloh, Hospital Kuala Lumpur and Hospital Tuanku Ja’afar, Seremban), in collaboration with professors from Yale University, who have extensive experience in using TCZ to treat COVID-19 patients.

MoH Director-General Datuk Dr Noor Hisham Abdullah lauded the initiative which involved a partnership between the public and private sectors. He said: “We are heartened to see the various efforts from private organisations in helping the country face the multitude of challenges due to the pandemic.

"I am happy to note that the private sector is now contributing to the progress of urgent research work such as this clinical trial. We hope that they will continue to support the government's efforts to fight this pandemic from all angles, including to find effective and safe treatments for COVID-19 patients. It is also important for researchers to follow protocols and not compromise on quality and safety," he added.

An initial study by UM Faculty of Medicine (UMFOM) found that TCZ administration prevented six out of eight severe COVID-19 patients from needing mechanical ventilation, which carries a high risk of mortality.

“We are pleased to announce Yayasan Sime Darby’s support for the clinical trial on this treatment to help mitigate the severity of the infection. This can subsequently reduce the number of patients requiring support by ventilators, which are in short supply,” said Sime Darby Berhad Group Chief Executive Officer Dato’ Jeffri Salim Davidson. Sime Darby Berhad is one of three Yayasan Sime Darby donors.

Dean of UMFOM Professor Dato’ Dr Adeeba Kamarulzaman who is the study’s Principal Investigator said the clinical trial which will compare TCZ with an immunosuppressant drug Methylprednisolone, is important to ascertain the ideal time to start the TCZ treatment. She noted: “It is also to determine if TCZ has better outcomes on patients and to identify any potential side effects so that the drug can be used safely and effectively.”

Dr Adeeba emphasised the importance of the trial as it could help clinicians find the best treatment to reduce morbidity and mortality associated with COVID-19 infection. She said such initiatives will encourage collaborative research efforts, as well as knowledge sharing among healthcare professionals locally and abroad, to save precious time and avoid overlapping research work.

“We are grateful to the Ministry of Health, Yayasan Sime Darby as well as other organisations and individuals who have come forward in support of this important clinical trial. We are proud to announce that we have reached the fund-raising target of RM1.5 million which will enable us to conduct the trial,” she added.

YSD has so far committed more than RM5.6 million for more than 30 COVID-19 Emergency Response Initiatives, to support efforts that address the immediate needs of individuals and communities impacted by the pandemic.

The funds are used to support medical providers and frontliners; vulnerable communities such as B40 households, Orang Asli communities, people with disabilities, public university students; a wildlife conservation centre, as well as underprivileged employees of Sime Darby Berhad and Sime Darby Property Berhad.

These initiatives would not be possible without the generous contributions from the three Sime Darby companies as well as project partners for coordinating the distribution of assistance.

The project partners are Sime Darby Plantation Berhad, Sime Darby Industrial Sdn Bhd, the Government-Linked Companies (GLC) and Government-Linked Investment Companies (GLIC) Disaster Response Network (GDRN), MERCY Malaysia, Pusat Hal Ehwal Pelajar Universiti Kebangsaan Malaysia (HEP-UKM), Malaysia International Search & Rescue (MISAR), University Malaya Medical Centre (UMMC), Perak State Park Corporation (PSPC), the Cultural Economy Development Agency (CENDANA), Tesco Malaysia, Econsave, Kechara Soup Kitchen, Dignity for the Children Foundation, UMFOM, Pusat Pengurusan Wakaf, Zakat dan Endowmen (WAZAN) at Universiti Putra Malaysia (UPM), OKU Sentral, Borneo Sun Bear Conservation Centre (BSBCC), The Lost Food Project and the Sarawak Federation of Chinese Associations.

-ENDS-

About Yayasan Sime Darby

Yayasan Sime Darby, or Sime Darby Foundation, was established in 1982 and is the philanthropic arm of Sime Darby Plantation Berhad, Sime Darby Property Berhad and Sime Darby Berhad.

With a vision to lead and make a sustainable impact and difference in the lives of others, YSD’s objectives are supported by its five pillars: education; environment; community & health; sports; arts & culture. While led by independent members of a Governing Council and managed by a dedicated team, YSD works closely with the three Sime Darby companies in areas of mutual interest.

Since its inception, YSD has awarded scholarships worth RM289.7 million to 4,440 students both in Malaysia and abroad. Under its Community & Health pillar, YSD supports initiatives to promote the well-being of disadvantaged people irrespective of race, culture, religion, creed or gender — the YSD Sinar Harapan initiative commits RM1,000,000 annually, majority of which goes to the provision of school supplies for the underprivileged and a smaller amount for in-kind assistance during festive seasons.

YSD’s conservation projects include the Sime Darby Plant–A–Tree programme in Pahang and Perak and the Protect Team to Combat Wildlife Poaching and Trafficking in Sabah. YSD is also actively involved in the development and improvement of sports in Malaysia — the YSD Chairman’s Trophy under the Sime Darby Football Development Programme (SDFDP) for example, aims to develop children (aged 8-15) to become multi-skilled professional footballers. Under the Arts & Culture pillar, YSD supports the development of a vibrant arts community in Malaysia through initiatives such as the biennial YSD Arts Festival (YSDAF) and ASK Dance Company’s Forging Traditions: Traditional Dance Training for Trainers Workshop.

For more information on YSD, visit www.yayasansimedarby.com

Issued by Yayasan Sime Darby Public Relations

For more information, please contact the PR team:

Laili Ismail
03-7623 7119
norlaili.ismail@simedarby.com

Wan Mohamad Akid W. Zaid
03-7623 7120
wan.mohamad.akid@simedarby.com

Share

Related posts

3 February 2023

Sime Darby Plantation’s palm oil exports to United States given greenlight after review by US Customs


Read more
8 December 2022

Sime Darby Plantation announces 2050 net-zero commitment with clear roadmap


Read more
29 November 2022

Sime Darby Plantation, Intan Hebat Baru and Wild Asia Join Forces to Raise Palm Oil Small Producers’ Standards


Read more
WHO WE ARE

About Us
Sime Darby Plantation Worldwide
Our Journey
Our Products
Our Leaders
Our Awards and Recognitions
Corporate Governance

INNOVATION

Overview
GenomeSelect™
Precision Agriculture
Automating Plantations
Eco-Solutions
Food Science
Innovation Challenge

SUSTAINABILITY

Overview
Climate Action
Human Rights
Responsible Sourcing
Reports, Policies and Statements

INVESTOR RELATIONS

Overview
Stock and Shareholder Information
Financial Information
Operational Information
Investor Resources
Analyst Coverage
ESG Index and Credit Ratings
Bursa Announcements
Annual Reports and Presentations

WHAT WE DO

Our Strategy
Our Businesses

Web Design Company

MEDIA

Press Releases and Public Updates
Resource Centre
Notices

OUR PEOPLE

Growing Together
Opportunities
What Do Our People Say?
Connect With Us

CONTACT US

© Copyright Sime Darby Plantation Berhad.
All Rights Reserved.

Terms of Use Important Notice Personal Data Protection Act 2010

    #SDPnetzero



      This website uses cookies in order to offer you the most relevant information. Please accept cookies for optimal performance.

      Read More



      Accept

      Ignore


      Manage consent

      Privacy Overview

      This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
      Necessary
      Always Enabled
      Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
      CookieDurationDescription
      cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
      cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
      cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
      cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
      cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
      viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
      Functional
      Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
      Performance
      Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
      Analytics
      Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
      Advertisement
      Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
      Others
      Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
      SAVE & ACCEPT
    • How we use Cookies

      A cookie is a small file which asks permission to be placed on your computer’s hard drive. Once you agree, the file is added and the cookie helps analyse web traffic or lets you know when you visit a particular site. Cookies allow web applications to respond to you as an individual. The web application can tailor its operations to your needs, likes and dislikes by gathering and remembering information about your preferences.

      We use traffic log cookies to identify which pages are being used. This helps us analyse data about web page traffic and improve our website in order to tailor it to customer needs. We only use this information for statistical analysis purposes and then the data is removed from the system.

      A cookie in no way gives us access to your computer or any information about you, other than the data you choose to share with us.

      You can choose to accept or decline cookies. Most web browsers automatically accept cookies, but you can usually modify your browser setting to decline cookies if you prefer. This may prevent you from taking full advantage of the website.